# Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of Acute Bacterial Rhinosinusitis

> **NCT00493038** · PHASE4 · TERMINATED · sponsor: **Bayer** · enrollment: 293 (actual)

## Conditions studied

- Sinusitis
- Bacterial Infections

## Interventions

- **DRUG:** Moxifloxacin (Avelox, BAY12-8039)
- **DRUG:** Amoxicillin/Clavulanate

## Key facts

- **NCT ID:** NCT00493038
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-02
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 293 (ACTUAL)
- **Why stopped:** The study was prematurely terminated due to slow enrollment beyond the planned study timelines.
- **Last updated:** 2014-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00493038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00493038, "Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of Acute Bacterial Rhinosinusitis". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00493038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*